Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published in May 2012
Author/s

author: Katia Boven  Simon Vanveggel  Beatriz Grinsztejn  Jean-Michel Molina  Michael Saag  Bonaventura Clotet Sala  Pedro Cahn 

Publication date May 1, 2012
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item